Tagged with IMBA

Regulatory Reform: Zimbabwe
Patents & Trademarks: Zimbabwe
Product Liability: Zimbabwe
Traditional Medicines and OTC Products: Zimbabwe
Marketing, Manufacturing, Packaging & Labeling, Advertising: Zimbabwe
Preclinical and Clinical Trial Requirements: Zimbabwe
Regulatory, Pricing and Reimbursement Overview: Zimbabwe
Interview: Michael Krebs – Managing Director, Institute of Molecular Biotechnology (IMBA), Austria
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here